Pfizer CEO Said COVID-19 Vaccines Contain Microchips?
A 2018 video with Albert Bourla speaking has nothing to do with COVID-19 or vaccines explains Dan Evon in his article. So don’t get any weird ideas, Pfizer CEO Albert Bourla spoke at WEF 2018 about electronic pills which contain some sort of “bio chip”. That the Pfizer’s anti-Covid pill represent the new frontier of coronavirus treatment must not be confusing. PAXLOVID ™, born in Pfizer’s laboratories, it would be the first oral antiviral of its kind.
During a round table at the World Economic Forum 2018, Bourla answered an interrogation, concerned that there is no guarantee that a patient was taking a prescribed drug:
“I think it’s fascinating what is happening in this area right now. The Food and Drug Administration (FDA) approved the first electronic pill, if I may call it that. It’s basically a biological chip, but it’s in a tablet. And as soon as you take the tablet and it dissolves in the stomach, it sends a signal that you have taken the tablet. Imagine the impact this has on compliance. This allows insurance companies to know that patients are taking the medications they should be taking. What is happening in this area is fascinating. “
FDA article of approval of this type of pill in 2017 www.fda.gov/news
But what are these electronic pills?
The digital pill, more intelligence for the healthcare of the future
The digital pill doesn’t just allow you to administer drugs to specific parts of the body, eliminating side effects, but also to monitor from the inside the patient’s status, through sensors and cameras, and transmit the data to devices capable of reading them.
Smart pill technology is most likely destined to play a major role in future healthcare developments as it introduces a method of drug delivery that goes far beyond traditional therapy. Integrated sensors and cameras inside small edible devices allow for better diagnostics and help doctors to monitor the bodily functions of their patients in real time. In addition, they allow drugs to be administered in a very precise way in specific parts of the body, eliminating possible side effects of traditional drugs.
A capsule that transmits data via Bluetooth
While the technology still has much room for improvement, researchers are completing advanced solutions that have great potential to change the way doctors diagnose and treat various conditions. One of these, the brainchild of researchers from MIT, Draper Laboratory and Brigham and Women’s Hospital, consists of an ingestible capsule made with 3D printing technology that transmits data via Bluetooth. Once the capsule has been swallowed, it opens two Y-shaped arms and lodges in the patient’s stomach, where it can remain for a month. In this period, the capsule collects information from the patient’s body and transmits the data to the user’s smartphone. Full article https://www.farmacianews.it/lla-pillola-digitale-piu-intelligenza-per-la-sanita-del-futuro/
“Artificial intelligence is a fundamental ingredient for digital transformation, and an essential tool for the new medicine, which will take therapy ‘beyond the pill'”, sottolinea Päivi Kerkola, Country Manager of Pfizer Italia.
And Pfizer explains: Approaches to digital medicine such as the one the PfIRe lab team is using can provide a more comprehensive picture for scientists, and this can have a lasting impact on how Pfizer develops therapies.
“What is happening in the PfIRe laboratory was called the future of medicine “, says David Caouette, head of Digital Data Science with Pfizer. “Ma sta accadendo ora – But it’s happening now.”
WILL SAMSUNG START MAKING PFIZER MEDICINES? YOU WERE NOT WRONG TO READ
NEWS A FEW WEEKS AGO: Not just technology. The South Korean giant Samsungin fact, it is also very active in other areas, including biotechnology. The Samsung Biologics division, founded in 2011 and based in the futuristic city of Songdo, represents in South Korea a national excellence in the field and, soon, could become the protagonist of an important partnership: the one with Pfizer for the production of Covid vaccines.
The indiscretion, reported by the “Corriere della Sera” and disseminated by the South Korean media, including the Korea Herald, took shape after the recent meeting, held in New York, between the president of the Asian country Moon Jae-in and the CEO of the US pharmaceutical company, Albert Bourla. At the center of the meeting, according to what was leaked, the vaccination cooperation between the two companies which would concern, on the one hand, the purchase of additional doses by the Seoul government in view of 2022, in the context of the fight against coronavirus, but also the possibility that soon the Covid vaccine can be developed right within the borders of South Korea, a country already among the leading pharmaceutical manufacturers in the world. Even the statements of the protagonists seem to presage this scenario. Bourla himself would have expressed appreciation for South Korea’s scientific technology and underlined how they exist “Many possibilities for Pfizer to strengthen cooperation with South Korea because it also produces other vaccines in addition to thati anti-C anti-Covid and medicines for other diseases “. INTEGRAL ARTICLE
WORLD ECONOMIC FORUM:
Transforming Health in the Fourth Industrial Revolution – Transforming Health in the Fourth Industrial Revolution
From ingestible sensors to AI-assisted physicians to affordable healthcare accessible to all, how are technologies shaping the future of healthcare?
Bourla’s statements at 45:20
IMPORTANT !: The material on this site (where there are no particular notices) can be copied and redistributed, provided the source is acknowledged. NoGeoingegneria assumes no responsibility for the articles and republished material.This blog does not represent a newspaper as it is updated without any periodicity. It cannot therefore be considered an editorial product pursuant to law no. 62 of 7.03.2001.